AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 78 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $530,000 | -95.5% | 150,000 | -89.3% | 0.54% | -95.2% |
Q2 2014 | $11,700,000 | +13.3% | 1,401,146 | -13.8% | 11.09% | +25.0% |
Q1 2014 | $10,323,000 | +240.1% | 1,625,703 | +281.9% | 8.87% | +184.0% |
Q4 2013 | $3,035,000 | -4.9% | 425,703 | 0.0% | 3.12% | -10.4% |
Q3 2013 | $3,193,000 | – | 425,703 | – | 3.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |